The
European Medicines Agency has launched a public consultation concerning the use
of antibiotics in animals.
One
of the topics included is:
“Advice
what the possible impact could be on the treatment of resistant bacteria in
humans of granting marketing authorisations for new classes of veterinary
antibiotics, and whether there is a need to restrict or ban the use in animals
of certain new classes of antimicrobials or antibiotic substances (especially
those that are important in human medicine) that are currently not authorised.
It is stressed that the advice could discuss a positive impact (for example,
better management of resistance in animals) or a negative impact (for example,
increased risk of development of resistance in humans).”
A
second important area is:
“Advice
on the risk mitigation options [alternatives], including an assessment of costs
and benefits, related with the use of certain classes of antibiotics or
antibiotic substances that are of critical importance in human medicine and are
currently authorised as veterinary medicinal products.”
To
access the document, go to EMA
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources